True Wealth Design, LLC Immunity Bio, Inc. Transaction History

True Wealth Design, LLC

$341 Billion
Q4 2025

A detailed history of True Wealth Design, LLC transactions in Immunity Bio, Inc. stock. As of the latest transaction made, True Wealth Design, LLC holds 20 shares of IBRX stock, worth $41. This represents 0.0% of its overall portfolio holdings.

Number of Shares

Holding current value

$41

% of portfolio

0.0%

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2025 Jan 08, 2026	BUY	$2.0 - $2.66 $40 - $53	20 New	20 $40,000
Q2 2025 Aug 06, 2025	BUY	$1.89 - $3.44 $22 - $41	12 Added 150.0%	20 $53,000
Q1 2025 May 13, 2025	BUY	$2.32 - $3.9 $18 - $31	8 New	8 $25,000

Others Institutions Holding IBRX

# of Institutions

299

Shares Held

137M

Call Options Held

2.59M

Put Options Held

3.35M

Vanguard Group Inc Valley Forge, PA

27.7M
Shares

$57.5 Million
0.0% of portfolio
Jane Street Group, LLC New York, NY

12.8M
Shares

$26.7 Million
0.01% of portfolio
Black Rock Inc. New York, NY

11.4M
Shares

$23.8 Million
0.0% of portfolio
State Street Corp Boston, MA

11.3M
Shares

$23.5 Million
0.0% of portfolio
Geode Capital Management, LLC Boston, MA

6.89M
Shares

$14.3 Million
0.0% of portfolio

View Full List

About ImmunityBio, Inc.

Ticker IBRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 400,304,000
Market Cap $833M
Description
ImmunityBio, Inc., a clinical-stage biotechnology company, develops therapies and vaccines to treat cancers and infectious diseases. It offers immunotherapy and cell therapy platforms, including antibody cytokine fusion proteins, synthetic immunomodulators, vaccine technologies, natural killer cells, and adaptive (T cell) immune systems. The com...

More about IBRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of True Wealth Design, LLC, based on Form 13F filings with the SEC.

News

Stay updated on True Wealth Design, LLC with notifications on news.

Account